The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Organization

banner

ChroMedX Submits PCT Patent Application for HemoPalm(TM) Blood Analysis System

30-Aug-2015 | Source : AG-IP News | Visits : 3157
TORONTO, ON - ChroMedX Corp., a developer of in vitro diagnostics and point-of-care testing (POCT) technologies announced in a press release the filing of a PCT (Patent Cooperation Treaty) Patent Application pertaining to the HemoPalm(TM) Cartridge and Analyzer system called "Joint Spectroscopic and Biosensor System for Point-of-Care Testing" (PCT/CA2015/050455).

PCT/CA2015/050455 has the potential to effectively extend the lifespan of the Company's issued US Patent pertaining to the HemoPalm(TM) system, and to provide patent protection outside the US, in particular Europe, China and India. The application claims priority to US Patent Application Nos. 62/114,700 and 62/006,066.
"We are continuing our efforts to expand the Company's Intellectual Property portfolio and are very pleased with the progress made to date", said Dr. Wayne Maddever, ChroMedX Corp., President & CEO.

The Company's HemoPalm(TM) and Ultrafiltration technologies are covered by several issued and pending patents. A list of issued and pending patents can be found on the company's website here: http://www.chromedx.com/intellectual-property/
 
share



Related Articles